Vaxxinity, Inc. logo

Vaxxinity, Inc.

NASDAQ:VAXX

Overview | Financials
Company Name Vaxxinity, Inc.
Symbol VAXX
Currency USD
Price 0.08
Market Cap 10,142,800
Dividend Yield 0%
52-week-range 0.001 - 1.61
Industry Biotechnology
Sector Healthcare
CEO Ms. Mei Mei Hu J.D.
Website https://www.vaxxinity.com

An error occurred while fetching data.

About Vaxxinity, Inc.

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2

Related Stocks

AnaptysBio, Inc. logo

AnaptysBio, Inc.

ANAB

40.33 USD

Vanda Pharmaceuticals Inc. logo

Vanda Pharmaceuticals Inc.

VNDA

5.1 USD

Quantum-Si incorporated logo

Quantum-Si incorporated

QSI

0.923 USD

UFP Technologies, Inc. logo

UFP Technologies, Inc.

UFPT

317.79 USD

Orthofix Medical Inc. logo

Orthofix Medical Inc.

OFIX

16.76 USD

Humacyte, Inc. logo

Humacyte, Inc.

HUMA

5.64 USD

Aveanna Healthcare Holdings Inc. logo

Aveanna Healthcare Holdings Inc.

AVAH

5.39 USD

Collegium Pharmaceutical, Inc. logo

Collegium Pharmaceutical, Inc.

COLL

37.5 USD

Financials

Numbers are in millions USD

Numbers are in millions USD